Search research articles
Contact Us
Filters
Showing results (921-930 of 1,303) with videos related to
Page
of 131
Sort By:
Brain : a Journal of Neurology
|
October 12, 2010
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Clifford R Jack, Heather J Wiste, Prashanthi Vemuri, et al.
Neurology
|
August 19, 2011
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD
J L Whitwell, K A Josephs, R Avula, et al.
Acta Neuropathologica
|
February 5, 2017
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)
Keith A Josephs, Melissa E Murray, Nirubol Tosakulwong, et al.
Frontiers in Neuroscience
|
August 14, 2012
Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression
Omid Kohannim, Derrek P Hibar, Jason L Stein, et al.
Environmental Health Perspectives
|
January 27, 2015
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study
Nour Abdo, Menghang Xia, Chad C Brown, et al.
Annals of Neurology
|
March 27, 2021
NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages
Ronald C Petersen, Heather J Wiste, Stephen D Weigand, et al.
Neurology
|
December 2, 2025
Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of Aging
Janina Krell-Roesch, Jeremy A Syrjanen, Allison L Hansen, et al.
British Journal of Anaesthesia
|
October 8, 2019
Exposure to surgery under general anaesthesia and brain magnetic resonance imaging changes in older adults
Juraj Sprung, S Chandralekha Kruthiventi, David O Warner, et al.
Neurobiology of Aging
|
July 28, 2016
Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum
David S Knopman, Clifford R Jack, Emily S Lundt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 13, 2021
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
Ondrej Libiger, Leslie M Shaw, Mark H Watson, et al.
Page
of 131
Search research articles
Search
Showing results (921-930 of 1,303) with videos related to
Sort By:
Page
of 131
Brain : a Journal of Neurology
|
October 12, 2010
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Clifford R Jack, Heather J Wiste, Prashanthi Vemuri, et al.
Neurology
|
August 19, 2011
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD
J L Whitwell, K A Josephs, R Avula, et al.
Acta Neuropathologica
|
February 5, 2017
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)
Keith A Josephs, Melissa E Murray, Nirubol Tosakulwong, et al.
Frontiers in Neuroscience
|
August 14, 2012
Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression
Omid Kohannim, Derrek P Hibar, Jason L Stein, et al.
Environmental Health Perspectives
|
January 27, 2015
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study
Nour Abdo, Menghang Xia, Chad C Brown, et al.
Annals of Neurology
|
March 27, 2021
NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages
Ronald C Petersen, Heather J Wiste, Stephen D Weigand, et al.
Neurology
|
December 2, 2025
Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of Aging
Janina Krell-Roesch, Jeremy A Syrjanen, Allison L Hansen, et al.
British Journal of Anaesthesia
|
October 8, 2019
Exposure to surgery under general anaesthesia and brain magnetic resonance imaging changes in older adults
Juraj Sprung, S Chandralekha Kruthiventi, David O Warner, et al.
Neurobiology of Aging
|
July 28, 2016
Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum
David S Knopman, Clifford R Jack, Emily S Lundt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 13, 2021
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
Ondrej Libiger, Leslie M Shaw, Mark H Watson, et al.
Page
of 131